


Abaloparatide Promising for Osteoporosis; NICE Draft Guidelines Include Secukinumab for Ankylosing Spondylitis
Abaloparatide May Boost BMD in Older Women with Osteoporosis

FDA Issues Stronger Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Warning

• By Lorraine L. Janeczko
• By Michele B. Kaufman, PharmD, CGP, RPh
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Visit the official website for the American College of Rheumatology.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.